Treatment of hepatitis C 2010: a focus on protease inhibitors.
作者信息
Lemon Michael
机构信息
SDSU College of Pharmacy, Department of Pharmacy Practice, USA.
出版信息
S D Med. 2010 Jun;63(6):214-5.
PMID:20853592
Abstract
摘要
相似文献
1
Treatment of hepatitis C 2010: a focus on protease inhibitors.2010年丙型肝炎的治疗：聚焦蛋白酶抑制剂
S D Med. 2010 Jun;63(6):214-5.
2
Excitement grows for potential revolution in hepatitis C virus treatment.丙型肝炎病毒治疗潜在变革引发的兴奋之情与日俱增。
Nat Rev Drug Discov. 2010 Jul;9(7):501-3. doi: 10.1038/nrd3214.
3
Prisoners treated for hepatitis C with protease inhibitor, New York, USA, 2012.2012年，美国纽约，使用蛋白酶抑制剂治疗丙型肝炎的囚犯。
Emerg Infect Dis. 2015 Jan;21(1):186-8. doi: 10.3201/eid2101.141025.
4
Worth the wait. New, more effective therapies for hepatitis C are on the way.值得等待。治疗丙型肝炎的新型、更有效的疗法即将问世。
Posit Aware. 2011 Jan-Feb;23(1):15-8.
5
Interim results presented at EASL from PROVE 1 clinical trial of investigational drug telaprevir in patients with genotype 1 hepatitis C.在欧洲肝脏研究学会（EASL）上公布的关于研究性药物特拉匹韦用于1型丙型肝炎患者的PROVE 1临床试验的中期结果。
Gastroenterology. 2007 Jun;132(7):2283-4. doi: 10.1053/j.gastro.2007.04.063.
6
New hepatitis C regimen stimulates changes in therapy management.
Manag Care. 2011 Dec;20(12):41-2.
7
[A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].丙型肝炎治疗的新时代：“现在治疗可以个体化了”（医学博士德克·艾内克访谈）
MMW Fortschr Med. 2011 Jul 21;153(29-31):17.
8
Protease inhibitors in hepatitis C: from chronic disease to cure.丙型肝炎中的蛋白酶抑制剂：从慢性病到治愈
Ir Med J. 2011 Sep;104(8):230-1.
9
Hepatitis C virus therapies.丙型肝炎病毒疗法。
Nat Rev Drug Discov. 2006 Sep;5(9):715-6. doi: 10.1038/nrd2134.
10
PROVE data released on telaprevir.
AIDS Patient Care STDS. 2007 May;21(5):369. doi: 10.1089/apc.2007.9979.
Zotero 插件